Kilian Kelly

Kilian Kelly

Director/Board Member at CYNATA THERAPEUTICS LIMITED

Net worth: 7 735 $ as of 30/06/2026

Commercial Services
Health Technology
Consumer Services

Profile

Kilian Kelly is a Non-Executive Director at Cynata Therapeutics Ltd. since 2026.
Dr. Kelly is a member of the Regulatory Affairs Professionals Society, Royal Pharmaceutical Society of Great Britain, International Society for Cellular Therapy, Australian Institute of Company Directors, The Organisation for Professionals in Regulatory Affairs Ltd, The International Society for Stem Cell Research, and International Society For Cell & Gene Therapy.
Former roles include Senior Director-Drug Development at Aviragen Therapeutics, Inc. and Vice President-Regulatory & Clinical at Mesoblast Ltd. from 2009 to 2013.
Education includes a doctorate from the University of Strathclyde and a graduate degree from The Robert Gordon University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/06/2025 7,97,428 ( 0.33% ) 7 735 $ 30/06/2026

Kilian Kelly active positions

CompaniesPositionStart
CYNATA THERAPEUTICS LIMITED Director/Board Member 01/07/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
International Society For Cell & Gene Therapy
Corporate Officer/Principal -

Former positions of Kilian Kelly

CompaniesPositionEnd
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer 01/02/2013
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Kilian Kelly's experience

Training of Kilian Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

International Society For Cell & Gene Therapy